The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Daniel M. Musher

Infectious Disease Section

The Medical Care Line

Michael E. DeBakey Veterans Affairs Medical Center

Houston

USA

[email]@med.va.gov

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Infectious Disease Section, The Medical Care Line, Michael E. DeBakey Veterans Affairs Medical Center, Houston, USA. 2001 - 2009
  • Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas 77030, USA. 2005 - 2008
  • Medical Service (Infectious Disease Section), Houston Veterans Affairs Medical Center and the Departments of Medicine, Microbiology/Immunology, and Dermatology, USA. 2000 - 2005
  • Medical Service, Veterans Affairs Medical Center, and Department of Medicine, Baylor College of Medicine, USA. 2002
  • Department of Medicine, Veterans Affairs Medical Center, 2002 Holcombe Blvd, Houston, USA. 2001
  • VA Medical Center, Houston, TX 77030, USA. 2000

References

  1. Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Musher, D.M., Logan, N., Bressler, A.M., Johnson, D.P., Rossignol, J.F. Clin. Infect. Dis. (2009) [Pubmed]
  2. Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia. Musher, D.M., Rueda, A.M., Nahm, M.H., Graviss, E.A., Rodriguez-Barradas, M.C. J. Infect. Dis. (2008) [Pubmed]
  3. Treatment of clostridium difficile colitis in the critical care setting. Musher, D.M., Aslam, S. Crit. Care. Clin (2008) [Pubmed]
  4. Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. Musher, D.M., Logan, N., Mehendiratta, V., Melgarejo, N.A., Garud, S., Hamill, R.J. J. Antimicrob. Chemother. (2007) [Pubmed]
  5. Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay. Musher, D.M., Manhas, A., Jain, P., Nuila, F., Waqar, A., Logan, N., Marino, B., Graviss, E.A. J. Clin. Microbiol. (2007) [Pubmed]
  6. The association between pneumococcal pneumonia and acute cardiac events. Musher, D.M., Rueda, A.M., Kaka, A.S., Mapara, S.M. Clin. Infect. Dis. (2007) [Pubmed]
  7. Nontypeable Haemophilus influenzae as a cause of spontaneous bacterial peritonitis. Musher, D.M., Nichol, A.C., Rueda, A.M. J. Clin. Microbiol. (2006) [Pubmed]
  8. Effect of pneumococcal vaccination: a comparison of vaccination rates in patients with bacteremic and nonbacteremic pneumococcal pneumonia. Musher, D.M., Rueda-Jaimes, A.M., Graviss, E.A., Rodriguez-Barradas, M.C. Clin. Infect. Dis. (2006) [Pubmed]
  9. Nitazoxanide for the treatment of Clostridium difficile colitis. Musher, D.M., Logan, N., Hamill, R.J., Dupont, H.L., Lentnek, A., Gupta, A., Rossignol, J.F. Clin. Infect. Dis. (2006) [Pubmed]
  10. Administration of protein-conjugate pneumococcal vaccine to patients who have invasive disease after splenectomy despite their having received 23-valent pneumococcal polysaccharide vaccine. Musher, D.M., Ceasar, H., Kojic, E.M., Musher, B.L., Gathe, J.C., Romero-Steiner, S., White, A.C. J. Infect. Dis. (2005) [Pubmed]
  11. Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. Musher, D.M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., Hamill, R.J. Clin. Infect. Dis. (2005) [Pubmed]
  12. Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia. Musher, D.M., Montoya, R., Wanahita, A. Clin. Infect. Dis. (2004) [Pubmed]
  13. Contagious acute gastrointestinal infections. Musher, D.M., Musher, B.L. N. Engl. J. Med. (2004) [Pubmed]
  14. Conditions associated with leukocytosis in a tertiary care hospital, with particular attention to the role of infection caused by clostridium difficile. Wanahita, A., Goldsmith, E.A., Musher, D.M. Clin. Infect. Dis. (2002) [Pubmed]
  15. Association of hypercoagulable states and increased platelet adhesion and aggregation with bacterial colonization of intravenous catheters. Musher, D., Goldsmith, E., Dunbar, S., Tilney, G., Darouiche, R., Yu, Q., López, J.A., Dong, J.F. J. Infect. Dis. (2002) [Pubmed]
  16. Nonspecificity of assaying for IgG antibody to pneumolysin in circulating immune complexes as a means to diagnose pneumococcal pneumonia. Musher, D.M., Mediwala, R., Phan, H.M., Chen, G., Baughn, R.E. Clin. Infect. Dis. (2001) [Pubmed]
  17. Protection against bacteremic pneumococcal infection by antibody to pneumolysin. Musher, D.M., Phan, H.M., Baughn, R.E. J. Infect. Dis. (2001) [Pubmed]
  18. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. Musher, D.M., Bartlett, J.G., Doern, G.V. Arch. Intern. Med. (2001) [Pubmed]
  19. Antibody to capsular polysaccharide of Streptococcus pneumoniae at the time of hospital admission for Pneumococcal pneumonia. Musher, D.M., Phan, H.M., Watson, D.A., Baughn, R.E. J. Infect. Dis. (2000) [Pubmed]
  20. Genetic control of the immunologic response to pneumococcal capsular polysaccharides. Musher, D.M., Watson, D.A., Baughn, R.E. Vaccine (2000) [Pubmed]
 
WikiGenes - Universities